2021 Scientific Sessions

An Update on Periprocedural Medical Therapy

The Importance of Dual Pathway Inhibition in PAD
Connie N. Hess, M.D., FSCAI, University of Colorado School of Medicine, Aurora, CO
Post-PVI Pharmacotherapy: What to Use and What's the Right Duration?
Jun Li, M.D., FSCAI, University Hospitals Case Medical Center/Case Western Reserve Univ
Inhibit This: SGLT2 and PCSK9 Inhibitors in PAD
Marc P. Bonaca, MD, MPH, University of Colorado School of Medicine, Aurora, CO
The Current State of Supervised Exercise Therapy
Brett Carroll, MD, Beth Israel Deaconess Medical Center, Boston, MA
See more of: Peripheral Vascular